Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
We are seeking to out-license our innovative Soluleaves range More
The XGEL ™ polymer technology is available for licensing and replaces the need to use animal-derived gelatine in pharmaceutical and healthcare products More
Collagen-based biodegradable matrices for localized drug delivery More
Phytohealth Corporation: PH3 (PHN031, PHN033) - For osteoporosis and diabetic vascular complications
Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More
Pancreatin 10,000- 20,000 and 25,000 FIP- units of lipase per capsule More
Vitamin C offered in 300mg doses More
Innovative CHEWABLE TABLETS Iron based More
Vitamin C offered in 500mg doses alone More
A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More
Mix of usual vitamins for supplementation in adults or children. Vit A, B, C, D3, E + oligoelements More
Your selection
Browse By
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us